Abstract
In the spectrum of inflammatory demyelinating diseases (IDDs), the most common disorder is multiple sclerosis (MS). Clinical neuroradiology plays a crucial role in MS to establish the diagnosis, to provide a prognosis, and increasingly to monitor treatment efficacy and safety. Radiological techniques important in MS are MRI of the brain and spinal cord. Dissemination in time and space according to so-called McDonald criteria requires demonstration of lesions in the brain and spinal cord. In addition to the classical multiple sclerosis (MS) phenotypes, different MS variants have been described, which can be differentiated based on severity, clinical course, and lesion distribution; salient features will be discussed. Other forms of IDDs are now recognized as distinct entities and not MS variants, including acute disseminated encephalomyelitis (ADEM) and neuromyelitis optica spectrum disorders (NMOSD), and will be discussed in other chapters. Relapsing-remitting and secondary-progressive phenotypes are the most common forms of MS, and a fast lesion accrual earlier in the disease course is often found. A smaller number of patients have a progressive course from onset (primary-progressive MS) or a benign course with minimal or no disability >10–15 years after onset (benign MS). Monitoring in MS requires a standardized protocol to detect new lesions that may inform switching of disease-modifying treatments but also detect opportunistic infections such as progressive multifocal leukoencephalopathy (PML) in a preclinical stage.
This publication is endorsed by: European Society of Neuroradiology (www.esnr.org)
References
Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278–86.
McGuigan C, Craner M, Guadagno J, et al. Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. J Neurol Neurosurg Psychiatry. 2016;87:117–25.
Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72:800–5.
Rocca MA, Battaglini M, Benedict RH, et al. Brain MRI atrophy quantification in MS: From methods to clinical application. Neurology. 2017;88:403–13.
Rovira À, Sastre-Garriga J, Auger C, Rovira A. Idiopathic inflammatory demyelinating diseases of the brainstem. Semin Ultrasound CT MR. 2013;34:123–30.
Sastre-Garriga J, Pareto D, Rovira À. Brain atrophy in multiple sclerosis: clinical relevance and technical aspects. Neuroimaging Clin N Am. 2017;27:289–300.
Sati P, Oh J, Constable RT, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American imaging in multiple sclerosis cooperative. Nat Rev Neurol. 2016;12:714–22.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the “McDonald” criteria. Lancet Neurol. 2018;17:162–73.
Further Readings
Aliaga ES, Barkhof F. MRI mimics of multiple sclerosis. Handb Clin Neurol. 2014;122:291–316.
Bot JC, Barkhof F. Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques. Neuroimaging Clin N Am. 2009;19:81–99.
Calabrese M, Castellaro M. Cortical gray matter MR imaging in multiple cclerosis. Neuroimaging Clin N Am. 2017;27:301–12.
Dekker I, Wattjes MP. Brain and spinal cord MR imaging features in multiple sclerosis and variants. Neuroimaging Clin N Am. 2017;27:205–27.
Filippi M, Rocca MA. MR imaging of multiple sclerosis. Radiology. 2011;259:659–81.
Geraldes R, Ciccarelli O, Barkhof F, on behalf of the MAGNIMS study group, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol. 2018;14:213.
Hardy TA, Miller DH. Baló’s concentric sclerosis. Lancet Neurol. 2014;13:740–6.
Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol. 2012;11:157–69.
Rovira À, Wattjes MP, Tintoré M, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol. 2015;11:471–82.
Wattjes MP, Rovira À, Miller D, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nat Rev Neurol. 2015;11:597–606.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this entry
Cite this entry
Rovira, À., Barkhof, F. (2018). Multiple Sclerosis and Variants. In: Barkhof, F., Jager, R., Thurnher, M., Rovira Cañellas, A. (eds) Clinical Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-319-61423-6_70-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-61423-6_70-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61423-6
Online ISBN: 978-3-319-61423-6
eBook Packages: Springer Reference MedicineReference Module Medicine